Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,288.40 -6.14 -0.04%
S&P 500 1,647.38 -3.13 -0.19%
Nasdaq 3,453.14 -6.28 -0.18%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: New York
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

ABBV:US

45.5400 USD 1.0500 2.25%

As of 14:44:08 ET on 05/24/2013.

Company Profile for AbbVie Inc (ABBV)

AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, Hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.

Contact Information

AbbVie Inc

1 North Waukegan Road
North Chicago, IL 60064
United States
Phone: 1-847-932-7900

Key Executives for AbbVie Inc (ABBV)

Richard A Gonzalez "Rick"Chairman/CEOWilliam J ChaseExec VP/CFO
Laura J SchumacherExec VP:Bus Dev/Secy/Gen CnslCarlos AlbanExec VP:Commercial Operations
John M LeonardSenior VP/Chief Scientific OfcrTimothy J RichmondSenior VP:Human Resources
Azita Saleki-GerhardtSenior VP:OperationsMaria RivasVP:Global Medical Affairs
Larry PeepoVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil